Different Smoking Statuses on Survival and Emphysema in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

被引:9
|
作者
Ding, Qi [1 ]
Li, Jie [1 ]
Xu, Shudi [1 ]
Gao, Yanzhong [2 ]
Guo, Youmin [3 ]
Xie, Baozhu [1 ,4 ]
Li, Hua [1 ,4 ]
Wei, Xia [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Pulm & Crit Care Med, Hosp Xian Affiliated 9, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Radiol, Hosp Xian Affiliated 9, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Dept Radiol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
[4] Yanan Univ, Med Sch, Yanan, Shaanxi, Peoples R China
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2022年 / 17卷
关键词
chronic obstructive pulmonary disease; acute exacerbation; smoking; impulse oscillometry system; emphysema index; SMOKERS; COPD;
D O I
10.2147/COPD.S346456
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To investigate the association between different smoking statuses and survival and emphysema in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: This retrospective study included patients admitted from October 2014 to September 2017. Demographic, clinical, laboratory, imaging, impulse oscillometry, and traditional pulmonary function data were collected. The relationship between smoking and EI was analyzed via binary logistic regression after adjusting for other factors. Survival was analyzed using the Kaplan-Meier method and the log rank test. Results: The patients with AECOPD (357 cases) were identified (and stratified into three groups: never smoked (NS; n=83), former smokers (FS, n=118), and current smokers (CS; n=156). Compared with CS, NS were older and predominantly female. No differences were observed in respiratory symptoms and acute exacerbation between CS and NS. NS had higher resistance and reaction in the central and peripheral airways, while CS exhibited more severe diffuse dysfunction. CS demonstrated more severe and extensive emphysema. Smoking was an independent risk factor for emphysema after adjusting for age, forced expiratory volume in the first second over predicted value, BMI, leukocyte count, and carbon monoxide transfer coefficient. No difference in 5-year survival rates between NS and CS was established. Conclusion: CS has the worst pulmonary function, suggesting a more important destruction of the lung parenchyma, while AECOPD without smoking risk factors mostly affects the airways. Impulse oscillometry can be used for imaging airway-dominant AECOPD. There was no difference in the 5-year survival rate.
引用
收藏
页码:505 / 515
页数:11
相关论文
共 50 条
  • [21] Role of Cardiac Biomarkers in Patients of Chronic Obstructive Pulmonary Disease with Acute Exacerbation
    Raghu, R., V
    Mawari, Govind
    Kumar, Naresh
    Daga, Mradul Kumar
    Gautam, Sachin
    Aarthi, J.
    Chand, Siddharth
    Ritchie, Nupur
    Rana, Gunjan
    Acharya, Shubho
    Sen, Parikshit
    Chaudhary, Divyansh
    Kain, Pratischtha
    Garg, Nishant
    Bhoria, Dhruv
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2022, 13 (03) : 161 - 165
  • [22] The concept of risk factors in assessing the impact of smoking on an exacerbation of chronic obstructive pulmonary disease
    Zhukova, O. V.
    Konyshkina, T. M.
    Kononova, S. V.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (03) : 23 - 26
  • [23] Different pattern of viral infections and clinical outcomes in patient with acute exacerbation of chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with pneumonia
    Kim, Ho-Cheol
    Choi, Sang-Ho
    Huh, Jin-Won
    Sung, Heungsup
    Hong, Sang Bum
    Lim, Chae-Man
    Koh, Younsuck
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (12) : 2092 - 2099
  • [24] Pharmacoeconomic Analysis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Iqbal, Muhammad Shahid
    Al-Saikhan, Fahad, I
    Ahmed, Nehad J.
    Iqbal, Muhammad Zahid
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (04) : 59 - 66
  • [25] Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Kim, Sung Kyu
    Kim, Young Sam
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2005, 48 (04): : 385 - 390
  • [26] Predicting Acute Exacerbation Phenotype in Chronic Obstructive Pulmonary Disease Patients Using VGG-16 Deep Learning
    Feng, Shengchuan
    Zhang, Ran
    Zhang, Wenxiu
    Yang, Yuqiong
    Song, Aiqi
    Chen, Jiawei
    Wang, Fengyan
    Xu, Jiaxuan
    Liang, Cuixia
    Liang, Xiaoyun
    Chen, Rongchang
    Liang, Zhenyu
    RESPIRATION, 2025, 104 (01) : 1 - 14
  • [27] Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease
    Rammaert, Blandine
    Verdier, Nicolas
    Cavestri, Beatrice
    Nseir, Saad
    RESPIROLOGY, 2009, 14 (07) : 969 - 974
  • [28] Blood Eosinophilia in Acute Exacerbation Patients with Chronic Obstructive Pulmonary Disease
    Ahmad, Atiq
    Ayyaz, Muhammad
    Punshi, Avinash
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (02): : 345 - 346
  • [29] Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease
    Liu, Dong
    Peng, Shao-Hua
    Zhang, Jing
    Bai, Si-Hong
    Liu, Hai-Xia
    Qu, Jie-Ming
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1265 - 1273
  • [30] Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?
    Vondracek, SF
    Hemstreet, BA
    PHARMACOTHERAPY, 2006, 26 (04): : 522 - 532